Inflammation in Myocardial Ischemia/Reperfusion Injury: Underlying Mechanisms and Therapeutic Potential
Acute myocardial infarction (MI) occurs when blood flow to the myocardium is restricted, leading to cardiac damage and massive loss of viable cardiomyocytes. Timely restoration of coronary flow is considered the gold standard treatment for MI patients and limits infarct size; however, this intervent...
Main Authors: | Jamie Francisco, Dominic P. Del Re |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/12/11/1944 |
Similar Items
-
Platelet Contributions to Myocardial Ischemia/Reperfusion Injury
by: Nancy Schanze, et al.
Published: (2019-06-01) -
IL‐38 attenuates myocardial ischemia–reperfusion injury by inhibiting macrophage inflammation
by: Yuzhen Wei, et al.
Published: (2023-06-01) -
Characterization of early myocardial inflammation in ischemia-reperfusion injury
by: Qihong Wu, et al.
Published: (2023-02-01) -
Clinical manifestations and basic mechanisms of myocardial ischemia/reperfusion injury
by: Chiu-Fen Yang
Published: (2018-01-01) -
Recombinant Klotho Protein Ameliorates Myocardial Ischemia/Reperfusion Injury by Attenuating Sterile Inflammation
by: Jinwoo Myung, et al.
Published: (2022-04-01)